Background: Clinical trial evidence supports an early invasive strategy for treatment of pts with high-risk non-ST-segment elevation (NSTE) acute coronary syndromes (ACS). This approach has not been evaluated in contemporary practice in North America. Methods: We included NSTEMI pts (CK-MB or troponin >upper limit of normal) from the US CRUSADE Initiative (n=38,373; 394 hospitals, 49 states, 2000-02) and the first Canadian ACS (n=5,312 suspected ACS; 51 hospitals, 9 provinces, 1999-2001), and second Canadian (n=1,258 suspected NSTE ACS; 31 hospitals, 7 provinces, 2002-03) Registries. Pts were divided into risk categories by a modified PURSUIT score. Results: Compared with Canadians, US pts were younger, more likely to be female and to have a higher rate of prior hypertension, diabetes, heart failure, revascularization, and initial ST depression (all p<0.0001). US pts had higher initial (< 24 hr) use of clopidogrel/ ticlopidine and GP IIb-IIIa inhibitors; aspirin and heparin use were lower (all p< 0.05). Table shows differences in risk level, angiography rates/timing, revascularization rates, and unadjusted clinical outcomes (all p< 0.02; * 25th, 75th percentiles). Conclusions: The inverse relation between risk level and both frequency and timing of angiography for pts in both countries suggests that a risk stratification-guided approach is not consistently employed. While initial risk is lower, Canadian pts have fewer in-hospital procedures and higher rates of repeat MI. .
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